Related Experiment Video
Updated: Jan 28, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Prosthetic pulmonary valve and conduit endocarditis in congenital heart disease
Fernando Rebollal-Leal1, Raúl Felipe-Abella2, Francisco Gutierrez-García3
11 Department of Cardiology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Insights
Prosthetic pulmonary valve endocarditis is rare in congenital heart disease patients but causes significant complications and often needs surgery. Further research is vital for better management strategies.
Area of Science:
- Cardiology
- Infectious Diseases
- Pediatric Cardiology
Background:
- Pulmonary valve replacement is a common procedure for congenital heart disease.
- Prosthetic valve endocarditis in this specific patient group is poorly understood.
Purpose of the Study:
- To review the management and outcomes of infective endocarditis in patients with prosthetic pulmonary valves or right ventricle-to-pulmonary artery conduits.
Main Methods:
- A multi-institutional cohort study involving 10 patients.
- Analysis of patient demographics, causative organisms, treatments, and complications.
Main Results:
- The median age at endocarditis diagnosis was 24 years.
- Staphylococcus and Streptococcus species were the most common pathogens.
- Five patients required surgical intervention due to severe complications like renal damage, hemoptysis, and septic shock.
- No in-hospital or follow-up mortality was observed.
Conclusions:
- Pulmonary prosthetic valve endocarditis is uncommon but linked to substantial morbidity and a high likelihood of surgery.
- Larger studies are necessary to establish optimal management protocols.
Background:
Pulmonary valve replacement is one of the most common procedures in patients with congenital heart disease. Little is known about prosthetic valve endocarditis in this population.
Objectives:
To review management and outcomes of pediatric and adult patients with a prosthetic pulmonary valve or right ventricle-to-pulmonary artery conduit infective endocarditis.
Methods And Results:
A multiinstitutional cohort of 10 patients is reported. Median age at endocarditis was 24 years (range 8-41 years). The most common causative organisms were Staphylococcus ( n = 4) and Streptococcus species ( n = 2). In addition to medical treatment, 5 patients required surgery. Majors complications such as renal damage, life-threatening hemoptysis, and septic shock were observed. No patient died in hospital or during follow-up.
Conclusions:
Pulmonary prosthetic valve endocarditis is a rare condition associated with significant morbidity and a high risk of requiring operative intervention. Larger studies are required to optimize the management.
More Related Videos
09:57Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Anatomy of the Heart
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction